⌘K

Login Start Free

Home/Filings/4/0001266375-08-000022

4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001266375-08-000022

CIK 0000835887operating

View on SEC.gov Company Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 2:23 PM ET

Size

14.1 KB

Accession

0001266375-08-000022

Insider Transaction Report

Form 4

Period: 2008-05-14

PROGENICS PHARMACEUTICALS INCPGNX

Director

Transactions

Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-05-14−2,500→ 0 total
Exercise: $4.41From: 2003-04-01Exp: 2013-05-31→ Common Stock (2,500 underlying)
Exercise/Conversion
Common Stock
2008-05-14$4.41/sh+2,500$11,025→ 73,500 total

Holdings

Common Stock
(indirect: By Partnership)
16,500

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000835887

Filing Metadata

Form type: 4
Filed: May 15, 8:00 PM ET
Accepted: May 16, 2:23 PM ET
Size: 14.1 KB

View on SEC.gov